GlassScriptPhysician profile
Aruj Ali
NPI 1265174254
$7,603.65
in general payments reported to CMS, 2019-2025
18 companies · $2,098 in 2025
The $2,098 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $79.92 · 2023: $2,747 · 2024: $2,679 · 2025: $2,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,421 · Travel and Lodging: $2,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,420.58 |
| Travel and Lodging | $2,103.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $3,368.79 | 2022-2025 | |
| Alcon Vision LLC | $1,920.71 | 2023-2025 | Total30, Tryptyr, Clareon |
| Bausch & Lomb Americas INC. | $527.11 | 2023-2025 | Miebo, Vyzulta, Xiidra |
| Oyster Point Pharma, INC. | $361.38 | 2022-2025 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $280.23 | 2024-2025 | Xdemvy |
| Coopervision INC. | $215.80 | 2023-2025 | Cvi Contact Lens, Misight Contact Lens |
| Abbvie INC. | $209.43 | 2023-2024 | Durysta, Lumigan, Alphagan P |
| Johnson & Johnson Vision Care, INC. | $135.37 | 2025 | |
| Rxsight INC | $109.10 | 2023-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Horizon Therapeutics Plc | $108.94 | 2023 | Tepezza |
| Apellis Pharmaceuticals, INC. | $92.55 | 2023 | |
| Dompe US, INC. | $85.57 | 2022-2024 | Oxervate |
| Novartis Pharmaceuticals Corporation | $60.12 | 2023 | |
| Rayner Intraocular Lenses Limited | $30.17 | 2023 | Rayone Spheric, Omidria, Rayone Aspheric |
| Harrow Eye, LLC | $29.66 | 2024 | Vevye |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $28.08 | 2022 | |
| Sun Pharmaceutical Industries INC. | $20.47 | 2024 | |
| Glaukos Corporation | $20.17 | 2024 | Ce-Marked Kxla System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aruj Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.